The relationship between uric acid levels and Huntington's disease progression - PubMed (original) (raw)
The relationship between uric acid levels and Huntington's disease progression
Peggy Auinger et al. Mov Disord. 2010.
Abstract
Uric acid (UA) may be associated with the progression of Parkinson's disease and related neurodegenerative conditions; however, its association with Huntington's disease (HD) progression has not been explored. A secondary analysis of 347 subjects from the CARE-HD clinical trial was performed to examine the relationship between baseline UA levels and the level of functional decline in HD. Outcomes included change in scores at 30 months for the Unified Huntington's Disease Rating Scale components. There was less worsening of total functional capacity over time with increasing baseline UA levels (adjusted mean worsening in scores: 3.17, 2.99, 2.95, 2.28, 2.21, from lowest to highest UA quintile, P = 0.03). These data suggest a possible association between higher UA levels and slower HD progression, particularly as measured by total functional capacity. If confirmed, UA could be an important predictor and potentially modifiable factor affecting the rate of HD progression.
(c) 2009 Movement Disorder Society.
Similar articles
- Rate of functional decline in Huntington's disease. Huntington Study Group.
Marder K, Zhao H, Myers RH, Cudkowicz M, Kayson E, Kieburtz K, Orme C, Paulsen J, Penney JB Jr, Siemers E, Shoulson I. Marder K, et al. Neurology. 2000 Jan 25;54(2):452-8. doi: 10.1212/wnl.54.2.452. Neurology. 2000. PMID: 10668713 - Huntington's Disease Progression: A Population Modeling Approach to Characterization Using Clinical Rating Scales.
Sun W, Zhou D, Warner JH, Langbehn DR, Hochhaus G, Wang Y. Sun W, et al. J Clin Pharmacol. 2020 Aug;60(8):1051-1060. doi: 10.1002/jcph.1598. Epub 2020 May 16. J Clin Pharmacol. 2020. PMID: 32416008 - Complex movement behaviour and progression of Huntington's disease.
Andrich J, Saft C, Ostholt N, Müller T. Andrich J, et al. Neurosci Lett. 2007 Apr 18;416(3):272-4. doi: 10.1016/j.neulet.2007.02.027. Epub 2007 Feb 11. Neurosci Lett. 2007. PMID: 17321683 - Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.
Goh AM, Wibawa P, Loi SM, Walterfang M, Velakoulis D, Looi JC. Goh AM, et al. Australas Psychiatry. 2018 Aug;26(4):366-375. doi: 10.1177/1039856218791036. Epub 2018 Jul 16. Australas Psychiatry. 2018. PMID: 30012004 Review. - Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review.
Tsai CW, Lin SY, Kuo CC, Huang CC. Tsai CW, et al. PLoS One. 2017 Jan 20;12(1):e0170393. doi: 10.1371/journal.pone.0170393. eCollection 2017. PLoS One. 2017. PMID: 28107415 Free PMC article. Review.
Cited by
- Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration.
Chen X, Burdett TC, Desjardins CA, Logan R, Cipriani S, Xu Y, Schwarzschild MA. Chen X, et al. Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):300-5. doi: 10.1073/pnas.1217296110. Epub 2012 Dec 17. Proc Natl Acad Sci U S A. 2013. PMID: 23248282 Free PMC article. - Uric acid, hyperuricemia and vascular diseases.
Jin M, Yang F, Yang I, Yin Y, Luo JJ, Wang H, Yang XF. Jin M, et al. Front Biosci (Landmark Ed). 2012 Jan 1;17(2):656-69. doi: 10.2741/3950. Front Biosci (Landmark Ed). 2012. PMID: 22201767 Free PMC article. Review. - The PRO-ACT database: design, initial analyses, and predictive features.
Atassi N, Berry J, Shui A, Zach N, Sherman A, Sinani E, Walker J, Katsovskiy I, Schoenfeld D, Cudkowicz M, Leitner M. Atassi N, et al. Neurology. 2014 Nov 4;83(19):1719-25. doi: 10.1212/WNL.0000000000000951. Epub 2014 Oct 8. Neurology. 2014. PMID: 25298304 Free PMC article. - Potential contribution of the neurodegenerative disorders risk loci to cognitive performance in an elderly male gout population.
Han L, Jia Z, Cao C, Liu Z, Liu F, Wang L, Ren W, Sun M, Wang B, Li C, Chen L. Han L, et al. Medicine (Baltimore). 2017 Sep;96(39):e8195. doi: 10.1097/MD.0000000000008195. Medicine (Baltimore). 2017. PMID: 28953682 Free PMC article. - Low levels of serum urate are associated with a higher prevalence of depression in older adults: a nationwide cross-sectional study in Korea.
Kim WJ, Kim HR, Song JS, Choi ST. Kim WJ, et al. Arthritis Res Ther. 2020 May 6;22(1):104. doi: 10.1186/s13075-020-02192-1. Arthritis Res Ther. 2020. PMID: 32375903 Free PMC article.
References
- Beal MF. Mitochondria take center stage in aging and neurodegeneration. Ann Neurol. 2005;58:495–505. - PubMed
- Yu ZF, Bruce-Keller AJ, Goodman Y, Mattson MP. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res. 1998;53:613–625. - PubMed
- Kim TS, Pae CU, Yoon SJ, et al. Decreased plasma antioxidants in patients with Alzheimer’s disease. Int J Geriatr Psychiatry. 2006;21:344–348. - PubMed
- de Lau LM, Koudstaal PJ, Hofman A, Breteler MM. Serum uric acid levels and the risk of Parkinson disease. Ann Neurol. 2005;58:797–800. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- M01 RR000645/RR/NCRR NIH HHS/United States
- RR00645/RR/NCRR NIH HHS/United States
- R01 NS035284-03/NS/NINDS NIH HHS/United States
- NS R01-35284/NS/NINDS NIH HHS/United States
- RR01066/RR/NCRR NIH HHS/United States
- RR07122/RR/NCRR NIH HHS/United States
- M01 RR001066/RR/NCRR NIH HHS/United States
- M01 RR000052/RR/NCRR NIH HHS/United States
- RR00052/RR/NCRR NIH HHS/United States
- M01 RR007122/RR/NCRR NIH HHS/United States
- M01 RR000042/RR/NCRR NIH HHS/United States
- RR00042/RR/NCRR NIH HHS/United States
- RR00044/RR/NCRR NIH HHS/United States
- M01 RR000044/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical